Coronary computed tomography angiography (CCTA) 3D imaging of the heart greatly contributes to preventing heart attacks, compared to standard tests, a new study finds.
Infection with the human papillomavirus (HPV) is the most common cause for cervical cancers. Now, researchers have developed a promising therapeutic vaccine against precancerous lesions.
A survey found that many Americans use a device to monitor their heart, but few share that data with their doctor. Cardiologists explain when findings should be discussed with a medical professional.
The WHO lists vaccine hesitancy as a major threat to global health, but what exactly is it, and how can it be addressed? New research into these questions could open up ways to approach this issue.
The vaccine to protect against Hepatitis E is given in a 3-dose regimen. However, in an epidemic setting, two doses have also proven effective, a new study shows.
After a heart attack, women in Scotland are less likely to receive preventative medicine than men, a new study shows. This could put them at greater risk of further heart attacks, strokes and CVD.
UK scientists are harnessing the power of AI to assess the antimicrobial resistance of patients in intensive care units (ICUs) and identify sepsis-causing bloodstream infections.
Rsearchers developed a novel bioelectronic device that taps into the natural electrical activity of certain bacteria found on our skin, paving the way for a drug-free approach to managing infections.
People who have been fully vaccinated against Covid-19 have a significantly lower risk of developing more severe cardiovascular conditions linked to Covid-19 infection, a new study shows.
Mammography can lead to “false positives,” meaning they do not result in a breast cancer diagnosis. This may discourage some women from future screenings, according to a new study.
Protection from established Covid-19 vaccines wanes relatively quickly. A new vector vaccine elicits prolonged immune response in animal models, and maintains its efficacy over extended time.
New research reveals a promising approach to developing a universal influenza vaccine that confers lifetime immunity against an evolving virus considered most likely to trigger the next pandemic.
Staphylococcus aureus is a leading cause of hospital-acquired bacterial infection, associated with over one million deaths worldwide each year. Now, researchers could be one step closer to a vaccine.
Microproteins hold great promise, according to new research: Since they are only expressed by liver tumor cells, the proteins could serve as a potential target for cancer vaccine development.
Finnish researchers found that using a mobile application based on cognitive behavioral therapy can significantly boost success rates of people attempting to stop smoking.
The rate of sepsis in newborns across Sweden has greatly decreased – however, the use of antibiotics for sepsis prevention has not. A new study points out the extent of the overuse.
A new approach to vaccine development could produce vaccines before the disease-causing pathogen – such as a new variant of the coronavirus Sars-CoV-2 – even emerges.
The stiffer the arteries, the greater the cardiovascular risk, according to a new study. The researchers suggest using this as a predictive tool, and emphasise the utility of a specific clinical tool.
Antimicrobial-resistant infections have become a global threat, with an annual death toll of over 1 million. Now, reseachers created a promising vaccine candidate for antibiotic-resistant bacteria.
